Inquis Clinical Research   Report issue

For profit Phase 1
Founded: Toronto Canada

Organization Overview

First Clinical Trial
2020
NCT04507971
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Inquis Clinical Research | INQUIS Clinical Research | INQUIS Clinical Research Ltd.

Active Ingredients

Drugs in Phase 1 Trials (1)

human fecal microbiota (Reybota) (1 trial)

Drugs in Other Trials (6)

barley (1 trial)

d-allulose (1 trial)

dextrose (1 trial)

glucose (1 trial)

stevia (1 trial)

sucrose (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypertriglyceridemia (Phase 1)

Obesity, Metabolically Benign (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 6
  • # of Trial APIs: 7